Year End Offer

Drug Discovery Services Market By Type (Medicinal Chemistry Services, Biology Services, Pharmacokinetics and Drug Metabolism), By Drug Type (Small Molecules, Biologics), By Therapeutic Area (Oncology, Neurological Disorder, Respiratory Disease, Diabetes, Cardiovascular Disease), By Regions (North America, Europe, Asia Pacific, Rest of the World) - Global Forecast up to 2025

About the Report

About the Report

Global Drug Discovery Services Market By Type (Medicinal Chemistry Services, Biology Services, Pharmacokinetics and Drug Metabolism), By Drug Type (Small Molecules, Biologics), By Therapeutic Area (Oncology, Neurological Disorder, Respiratory Disease, Diabetes, Cardiovascular Disease), By Regions (North America, Europe, Asia Pacific, Rest of the World)-Global Forecast up to 2025.

This market research report includes a detailed segmentation of the global drug discovery services market by type (medicinal chemistry services, biology services, and pharmacokinetics and drug metabolism), by drug type (small molecules and biologics), by therapeutic area (oncology, neurological disorder, respiratory disease, diabetes, cardiovascular disease, and others), and by regions (North America, Europe, Asia Pacific, and Rest of the World).

Overview of the Global Drug Discovery Services Market Research:
Infoholic's market research report predicts that the global drug discovery services market will grow at a CAGR of 11.7% during the forecast period 2019-2025. Drug discovery refers to the process of identifying potential new medicines, and it involves a wide range of scientific disciplines, including biology, chemistry, and pharmacology. The process of drug discovery involves various methods such as identification of target molecule, candidate drug identification, characterization, screening, and assays for therapeutic efficacy. Once a candidate compound has shown its therapeutic value in these tests, it will begin the process of drug development prior to clinical trials. In recent years, there is a lot of interest in biologics-based drug discovery. Biologics drug discovery includes developing new novel antibodies, recombinant proteins, hormones, vaccines, cell therapy, and gene therapy for treating cancer, neurological disorders, cardiovascular disorders, and many others.

The upsurge in the externalization of R&D activities, rising expenditure on R&D, expiration of patents boosting the demand for drug discovery, and introduction of advanced technologies are few of the factors driving the growth of the drug discovery services market.

Increasing patient base for various chronic & lifestyle diseases and growing advancements in innovative technologies will enhance the revenue of the drug discovery services market in the next five years.
 
The industry generates the majority of the revenue from the key players operating in this field; few of them include Charles River Laboratories, Evotec SE, GVK Biosciences, Albany Molecular Research Inc., Domainex Ltd., Genscript Biotech Corporation, Syngene International Ltd., Eurofins Scientific SE, and Laboratory Corporation of America Holdings.
According to the Infoholic Research analysis, North America accounted for the largest share of the global drug discovery services market in 2018 and will retain a high position during the forecast period. North America is followed by Europe, with a share of more than 25% of the global market in 2018.

By Type:
Medicinal Chemistry Services
Biology Services
Pharmacokinetics and Drug Metabolism
In 2018, the medicinal chemistry services segment accounted for the largest share and is expected to grow at a high-double-digit CAGR during the forecast period. Increasing tendency of pharma companies to externalize discovery and development services, increasing number of drug discovery and development activities, and growing R&D expenditure are the key factors driving the growth of the medicinal chemistry services segment. The biology services segment is projected to grow at a high CAGR during the forecast period 2019-2025.

By Drug Type:
Small Molecules
Biologics
The small molecules segment occupied a significant share in 2018, and biologics is expected to grow at a high CAGR during the forecast period 2019-2025. The increasing use of small molecules drugs to treat chronic disease is leading to increased demand for these drugs.

By Therapeutic Area:
Neurological Disorder
Diabetes
Oncology
Respiratory Disease
Cardiovascular Disease
Others

Based on therapeutic areas, oncology dominated the market in 2018 and is expected to maintain its position throughout the forecast period. The high demand for cancer therapies due to the increasing number of cancer cases across the globe makes the segment a dominant shareholder in the coming years.

By Regions:
North America
Europe
Asia Pacific
Rest of the World
Based on geography, North America dominated the market in 2018 with a market share of over 40% and is expected to maintain this position throughout the forecast period. Increasing demand for personalized medicine, well-established healthcare sector, rising incidence of chronic disease, availability of advanced technologies, high healthcare expenditure, and rising growth of the biopharmaceutical market are few of the factors that make North America a dominant shareholder in the global drug discovery services market. Asia Pacific is projected to grow at the fastest rate during the forecast period 2019-2025.

Global Drug Discovery Services Market Research Competitive Analysis: The market is growing at a steady rate with a CAGR of 11.7% during the forecast period 2019-2025. The increasing burden of disease and the need for new therapeutic drugs have led to an increase in collaboration between companies for drug discovery services. For instance, in September 2019, German-based Evotec entered into a multi-year drug discovery collaboration agreement with Japanese pharma company Takeda Pharmaceutical Company Limited. According to the collaboration terms, Evotec will leverage its technology platform to establish five drug discovery programs in the field of oncology, neuroscience, gastroenterology, and rare diseases, which Takeda will advance into clinical development.

East Midlands' life sciences researchers and GSK entered into a strategic research collaboration for lung disease in February 2018, and the partnership is expected to accelerate discovery and development of innovative treatments for COPD and related airway diseases.

Key Vendors:
Charles River Laboratories
GVK Biosciences
Evotec SE
Albany Molecular Research Inc.
Domainex Ltd.
Genscript Biotech Corporation
Laboratory Corporation of America Holdings (LabCorp)
Syngene International Ltd.
Eurofins Scientific SE
Pharmaceutical Product Development
Jubilant Life Sciences
WuXi AppTec Co., Ltd.

Key Competitive Facts:
In 2019, Lundbeck acquired Abide Therapeutics for USD 250 million and takes control of Abide's drug discovery platform focused on serine hydrolases, which is a diverse enzyme class that accounts for roughly 1% of all proteins in mammals.
In May 2019, Amgen acquired Nuevolution for USD 167 million following their three-year collaboration, which is expected to boost the Amgen's drug discovery platform.

Benefits-The report provides complete details about the sub-segment of the global drug discovery services market. Thus, the key stakeholders can know about the major trends, drivers, investments, vertical player's initiatives, and government initiatives toward the drug discovery services segment in the upcoming years along with details of the pureplay companies entering the market. Moreover, the report provides details about the major challenges that are going to impact the market growth. Additionally, the report gives complete details about the key business opportunities to key stakeholders in order to expand their business and capture the revenue in specific verticals, and to analyze before investing or expanding the business in this market.

Key Takeaways:
Understanding the potential market opportunity with precise market size and forecast data.
Detailed market analysis focusing on the growth of the drug discovery services industry.
Factors influencing the growth of the drug discovery services market.
In-depth competitive analysis of dominant and pure-play vendors.
Prediction analysis of the drug discovery services market in both developed and developing regions.
Key insights related to major segments of the drug discovery services market.
Latest market trend analysis impacting the buying behavior of the consumers.
Key Stakeholders:

Products


Companies

Charles River Laboratories

GVK Biosciences

Evotec SE

Albany Molecular Research Inc.

Domainex Ltd.

Genscript Biotech Corporation

Laboratory Corporation of America Holdings (LabCorp)

Syngene International Ltd.

Eurofins Scientific SE

Pharmaceutical Product Development

Jubilant Life Sciences

WuXi AppTec Co., Ltd.

Table of Contents

Table of Contents

Table of Contents

1 Industry Outlook 7

1.1 Industry Overview 7

1.1.1 Overview 7

1.1.2 Global Driver for Pharmaceutical Demand: 8

1.1.3 R&D pipeline in pharmaceutical industry 8

1.1.4 Top pharma drugs by sales (USD Million) 9

1.2 Industry Trends 10

1.3 Total Addressable Market 10

2 Report Outline 12

2.1 Report Scope 12

2.2 Report Summary 12

2.3 Research Methodology 13

2.4 Report Assumptions 14

3 Market Snapshot 15

3.1 Market Definition-Infoholic Research 15

3.2 Need for discovery and development services 15

3.3 Segmented Addressable Market (SAM) 15

3.4 Trends of the drug discovery services Market 17

3.5 Related Markets 18

3.5.1 Pharmaceutical Contract Manufacturing Organization 18

3.5.2 Pharma contract research organization 19

4 Market Outlook 20

4.1 Market Segmentation 20

4.2 PEST Analysis 21

4.3 Porter 5 (Five) Forces 22

5 Market Characteristics 23

5.1 DRO -Market Dynamics 23

5.1.1 Drivers 24

5.1.1.1 Upsurge in outsourcing of R&D activities 24

5.1.1.2 Rising expenditure on research and development 24

5.1.2 Restraints 25

5.1.2.1 High cost for discovery and development of the drug 25

5.1.2.2 Strict regulations governing the drug development and ethical issues related to animal studies 25

5.1.3 Opportunities 26

5.1.3.1 Advent of innovative technology 26

5.1.3.2 Expiration of patent boosts demand for drug discovery 26

5.2 DRO-Impact Analysis 27

5.3 Key Stakeholders 28

6 Type: Market Size and Analysis 29

6.1 Overview 29

6.2 Medicinal chemistry services 31

6.3 Biology Services 32

6.4 Pharmacokinetics and drug metabolism 33

7 Drug Type: Market Size and Analysis 34

7.1 Overview 34

7.2 Small molecules 36

7.3 Biologics 37

8 Therapeutic area: Market Size and Analysis 39

8.1 Overview 39

8.2 Oncology 39

8.3 Neurological disorder 40

8.4 Respiratory disease 40

8.5 Diabetes 40

8.6 Cardiovascular disease 40

8.7 Others 41

9 Regions: Market Size and Analysis 42

9.1 Overview 42

9.2 North America 43

9.3 Europe 45

9.4 Asia Pacific 46

9.4.1 Overview 46

9.5 Rest of the World 47

10 Competitive Landscape 49

10.1 Overview 49

11 Vendors Profile 52

11.1 Charles River Laboratories 52

11.2 GVK Biosciences 55

11.3 Evotec SE 58

11.4 Albany Molecular Research Inc. (AMRI) 62

11.5 Domainex Ltd. 63

11.6 GenScript Biotech 65

12 Companies to Watch For 69

12.1 Laboratory Corporation of America Holdings (LabCorp) 69

12.2 Syngene International Ltd 71

12.3 Eurofin Scientific SE 73

12.4 Pharmaceutical product Development 76

12.5 Jubilant Life Sciences 77

12.6 WuXi AppTec Co., Ltd. 78

Annexure 81

Abbreviations 81


List of Figure

Charts

 

CHART 1 GLOBAL PHARMACEUTICAL R&D SPENDING (2010-2017) 9

CHART 2 PHARMACEUTICAL DRUGS BY SALES, 2018 10

CHART 3 RESEARCH METHODOLOGY OF GLOBAL DRUG DISCOVERY SERVICES MARKET 14

CHART 4 GLOBAL DRUG DISCOVERY SERVICES MARKET REVENUE, 2018-2025 (USD MILLION) 18

CHART 5 SEGMENTATION OF GLOBAL DRUG DISCOVERY SERVICES MARKET 21

CHART 6 PEST ANALYSIS OF GLOBAL DRUG DISCOVERY SERVICES MARKET 22

CHART 7 PORTER 5 FORCES ON GLOBAL DRUG DISCOVERY SERVICES MARKET 23

CHART 1 MARKET DYNAMICS-DRO ANALYSIS 24

CHART 2 DRO-IMPACT ANALYSIS OF GLOBAL DRUG DISCOVERY SERVICES MARKET 28

CHART 3 KEY STAKEHOLDERS 29

CHART 4 GLOBAL DRUG DISCOVERY SERVICES MARKET, BY TYPE, 2018 V/S 2025 (%) 30

CHART 5 GLOBAL DRUG DISCOVERY SERVICES MARKET REVENUE FORECAST, BY TYPE, 2018-2025 (USD MILLION) 30

CHART 6 GLOBAL DRUG DISCOVERY SERVICES MARKET REVENUE FORECAST, BY TYPE 2018-2025 (%) 31

CHART 7 MEDICINAL CHEMISTRY SERVICES MARKET REVENUE FORECAST, 2018-2025 (USD MILLION) 32

CHART 8 BIOLOGY SERVICES MARKET REVENUE FORECAST, 2018-2025 (USD MILLION) 33

CHART 9 PHARMACOKINETICS AND DRUG METABOLISM MARKET REVENUE FORECAST, 2018-2025 (USD MILLION) 34

CHART 10 GLOBAL DRUG DISCOVERY SERVICES MARKET, BY DRUG TYPE, 2018 V/S 2025 (REVENUE IN USD MILLION) 35

CHART 11 GLOBAL DRUG DISCOVERY SERVICES MARKET REVENUE FORECAST, 2018-2025 (USD MILLION) 36

CHART 12 GLOBAL DRUG DISCOVERY SERVICES MARKET REVENUE FORECAST, 2018-2025 (%) 36

CHART 13 SMALL MOLECULES MARKET REVENUE FORECAST, 2018-2025 (USD MILLION) 37

CHART 14 BIOLOGICS MARKET REVENUE FORECAST, 2018-2025 (USD MILLION) 38

CHART 15 GLOBAL DRUG DISCOVERY SERVICES MARKET, BY THERAPEUTIC AREA, 2018 (%) 40

CHART 16 GLOBAL DRUG DISCOVERY SERVICES MARKET BY GEOGRAPHICAL SEGMENTATION, 2018 V/S 2025 (USD REVENUE) 43

CHART 17 GLOBAL DRUG DISCOVERY SERVICES MARKET BY GEOGRAPHICAL SEGMENTATION, 2018 (USD REVENUE, % MARKET SHARE) 43

CHART 18 DRUG DISCOVERY SERVICES MARKET REVENUE IN NORTH AMERICA, 2018-2025 (USD MILLION) 45

CHART 19 DRUG DISCOVERY SERVICES MARKET REVENUE IN EUROPE, 2018-2025 (USD MILLION) 46

CHART 20 DRUG DISCOVERY SERVICES MARKET REVENUE IN ASIA PACIFIC, 2018-2025 (USD MILLION) 48

CHART 21 DRUG DISCOVERY SERVICES MARKET REVENUE IN REST OF THE WORLD, 2018-2025 (USD MILLION) 49

 

 


List of Table

Tables

 

TABLE 1 GLOBAL DRUG DISCOVERY SERVICES MARKET REVENUE, BY REGIONS, 2018-2025 (USD MILLION) 44

TABLE 2 OTHER VENDORS IN THE DRUG DISCOVERY SERVICES MARKET 52

TABLE 3 BUSINESS SUMMARY: CHARLES RIVER LABORATORIES 54

TABLE 4 BUSINESS SUMMARY: GVK BIOSCIENCES 57

TABLE 5 BUSINESS SUMMARY: EVOTEC SE 60

TABLE 6 BUSINESS SUMMARY: ALBANY MOLECULAR RESEARCH INC. 63

TABLE 7 BUSINESS SUMMARY: DOMAINEX LTD. 65

TABLE 8 BUSINESS SUMMARY: GENSCRIPT BIOTECH 67

TABLE 9 BUSINESS SUMMARY: LABORATORY CORPORATION OF AMERICA HOLDINGS 71

TABLE 10 BUSINESS SUMMARY: SYNGENE INTERNATIONAL LTD 72

TABLE 11 BUSINESS SUMMARY: EUROFIN SCIENTIFIC 74

TABLE 12 BUSINESS SUMMARY: PHARMACEUTICAL PRODUCT DEVELOPMENT 77

TABLE 13 BUSINESS SUMMARY: JUBILANT LIFE SCIENCES 78

TABLE 14 BUSINESS SUMMARY: WUXI APPTEC CO., LTD 79

You can also purchase parts of this report. Do you want to check out a section wise price list?

Why Buy From US?

RRR
Refine Robust Result (RRR) Framework

What makes us stand out is that our consultants follows Robust, Refine and Result (RRR) methodology. i.e. Robust for clear definitions, approaches and sanity checking, Refine for differentiating respondents facts and opinions and Result for presenting data with story

reach
Our Reach Is Unmatched

We have set a benchmark in the industry by offering our clients with syndicated and customized market research reports featuring coverage of entire market as well as meticulous research and analyst insights.

Research
Shifting the Research Paradigm

While we don't replace traditional research, we flip the method upside down. Our dual approach of Top Bottom & Bottom Top ensures quality deliverable by not just verifying company fundamentals but also looking at the sector and macroeconomic factors.

Insite
More Insights-Better Decisions

With one step in the future, our research team constantly tries to show you the bigger picture. We help with some of the tough questions you may encounter along the way: How is the industry positioned? Best marketing channel? KPI's of competitors? By aligning every element, we help maximize success.

Trust
Transparency and Trust

Our report gives you instant access to the answers and sources that other companies might choose to hide. We elaborate each steps of research methodology we have used and showcase you the sample size to earn your trust.

support
Round the Clock Support

If you need any support, we are here! We pride ourselves on universe strength, data quality, and quick, friendly, and professional service.

Why Client Choose Us?

400000+ Reports in repository
150+ Consulting project a year
100+ Analysts
8000+ Client Queries in 2022


Trusted By 2500+ Brands

What Our Clients Say About Us